Path to a Cure — Collaborative Research Grant
Supports collaborative, innovative research to advance CFTR gene repair and replacement therapies for cystic fibrosis using cutting-edge technologies.
Funder: Cystic Fibrosis Foundation
Due Dates (Anticipated): July 2026 (published full application deadline, projected) | November 2026 (full application deadline, projected)
Funding Amounts: Up to $1,000,000 in direct costs per year for up to 3 years, plus 12% indirect costs; minimum two projects per application.
Summary: Supports ambitious, collaborative research advancing CFTR gene repair and replacement for cystic fibrosis using cutting-edge technologies.
Key Information: Applicants must contact program staff for pre-approval before submission; failure to do so results in administrative withdrawal.
Description
This grant funds multi-investigator, collaborative research projects that contribute to the development of new therapies or therapeutic strategies for cystic fibrosis (CF), with a primary focus on advancing CFTR gene repair and replacement. Projects are expected to be ambitious, utilize innovative technologies, and aim to restore CFTR protein function by fixing or replacing the defective gene. The program strongly encourages collaborations that bring new investigators and novel approaches into the CF research community, and proposals should demonstrate synergy among at least two (up to four) related research projects unified by a central theme and supported by preliminary data.
